1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesInsulin Resistance, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, immune system disorder, metabolic disease, respiratory system disorder, type 1 diabetes mellitusRecruitingPhase 22026-08-13NCT07224321